Top Abstract Purchase Related
Home
>
Node
>
Subnode

The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers

Arbuzova, S.B.; Nikolenko, M.I.; Khlevnaia, L.A.; Fedotova, O.O.; Solov'eva, V.D.; Malova, S.A.

Tsitologiia i Genetika 32(1): 66-71

1998

ISSN/ISBN: 0564-3783
PMID: 9695254
Document Number: 491005
The role of maternal alpha-fetoprotein and chorionic gonadotprin screening in complex prenatal diagnosis of Down syndrome had been studied. The average markers' values in cases of fetus trisomy 21 were 0.67 MoM (AFP) and 2.68 MoM (HGG). The correlative dependence between the markers' levels in trisomy 21 and the date of testing have been found. The high efficiency of differentiative approach to invasive investigations in the older age group of pregnant (above 35 years old) on the basis of AFP and HGG screening has been established.

Document emailed within 1 workday
Secure & encrypted payments

Zilberstein, T.; Maymon, E. 1998: Prenatal diagnosis of Down's syndrome: prediction from maternal serum markers Harefuah 134(5): 393-396
Wasant, P.; Liammongkolkul, S. 2003: Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers in Thai pregnant women Southeast Asian Journal of Tropical Medicine and Public Health 34(Suppl 3): 244-248
Seror, V.; Costet, N.; Ayme, S. 2000: Prenatal screening for trisomy 21 with maternal serum markers: information for decision-making in pregnant women Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(5): 492-500
Li, G.; Huang, X. 1998: Clinical uses of maternal serum markers in the prenatal diagnosis Zhonghua Fu Chan Ke Za Zhi 33(4): 252-254
Davidson, R.G.; Sheffield, L.J. 1978: Hazards of prenatal detection of neural-tube defects by screening maternal serum for alpha-fetoprotein Canadian Medical Association Journal 118(10): 1186-1191
Tepe, J.M.; Huether, C.A.; Torfs, C.; Feuchtbaum, L. 1999: The effects of race, maternal age, income, and timing of first prenatal care on the utilization of prenatal diagnosis and the percent reduction of live births with Down syndrome in California, 1992 - 1995 American Journal of Human Genetics 65(4): A409
Ortega-Benito, J.M. 1995: Blood markers in the prenatal diagnosis of Down's syndrome: the triple test Medicina Clinica 105(7): 264-268
Wan, B.L. 1982: Presence of alpha-fetoprotein in maternal serum and amniotic fluid in prenatal diagnosis Zhonghua Fu Chan Ke Za Zhi 17(1): 39-42
Lamlertkittikul, S.; Chandeying, V. 2007: Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital Journal of the Medical Association of Thailand 90(10): 1970-1976
Sirichotiyakul, S.; Luewan, S.; Sekararith, R.; Tongsong, T. 2012: False positive rate of serum markers for down syndrome screening: does transportation have any effect? Journal of the Medical Association of Thailand 95(2): 152-155
Grabowska, A.; Madetko-Talowska, A.; Janeczko, M.; Majka, M.; Pietrzyk, J.J. 2011: Fetal CD34+ cells isolated from maternal blood and cytogenetics array as potential tools in screening, non-invasive prenatal diagnosis--preliminary research Przeglad Lekarski 68(1): 40-43
Lai, F.M.; Ng, C.C.M.; Yeo, G.S.H. 2004: Does maternal serum screening for Down syndrome induce anxiety in younger mothers? Singapore Medical Journal 45(8): 375-378
Bessho, T.; Kanazawa, R.; Shiotani, T.; Mitsuo, M.; Koyama, K. 1995: Maternal serum alpha-fetoprotein as a screening test for fetal down syndrome Nihon Sanka Fujinka Gakkai Zasshi 47(3): 237-243
Vikhliaeva, E.M. 1987: Topical diagnosis of disorders of maternal-fetal blood flow in the prenatal protection of the fetus in the placental insufficiency syndrome Vestnik Akademii Meditsinskikh Nauk SSSR 4: 28-35
Bergman, G.; Borgström, E.; Lundell, B.; Sonesson, S.-E. 2008: Improved prenatal diagnosis of congenital heart defects. a follow-up study of prenatal ultrasound screening Lakartidningen 105(12-13): 899-903
Lobaccaro, J.M.; Lumbroso, S.; Sultan, C. 1991: Androgen receptor gene polymorphism analysis: application to screening of heterozygote and to prenatal diagnosis of androgen insensitivity syndrome Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 185(6): 422-433
Riesco, M.; Sastre, P.; Barceló, A.; Pérez, G. 1999: Biochemical markers of bone remodeling. Apropos of osteoporosis screening Medicina Clinica 112(1): 39
Witters, I.; Moerman, P.; Fryns, J.P. 2002: Maternal serum positive triple test screening in a fetus with partial distal trisomy 7p associated with maternal 7p;18p translocation Genetic Counseling 13(1): 65-68
Cheng, P-Jen.; Chu, D-Chang.; Chueh, H-Yen.; See, L-Chu.; Chang, H-Chen.; Weng, D.Red-Helm. 2004: Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results American Journal of Obstetrics and Gynecology 190(2): 442-447
Selroos, O.B. 1984: Value of biochemical markers in serum for determination of disease activity in sarcoidosis Sarcoidosis 1(1): 45-49